Refurbish Life Sciences is researching and developing innovative new drug anticancer drugs and has a variety of new drug candidates ranging from third-generation immunotherapy drugs to fourth-generation cancer drugs.
Brain cancer glioblastoma
2019: Efficacy Effectiveness: In the first half of 2020: Clinical drug, toxicity studyFrom 2019 to 2020: Preclinical
2020: The goal of the Phase 1 clinical trial approach.
2021: The goal of the Phase 2 clinical trial approach.
Brain cancer glioblastoma identification patent
Patent for blood pressure medicine/ breast cancer indication effect